Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allergic inflammation

S R Durham1

  • 1Department of Allergy & Clinical Immunology, National Heart & Lung Institute, London, England.

Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Initial assessment of second generation of large-area picosecond photodetectors with multi-channel systems-on-a-chip readout.

The Review of scientific instruments·2025
Same author

BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007).

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2018
Same author

Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial.

Allergy·2018
Same author

EAACI guidelines on allergen immunotherapy: Executive statement.

Allergy·2018
Same author

Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients.

Allergy·2018
Same author

A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy.

Allergy·2017
Same journal

Comment on Elhani et al.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same journal

Bridging Rare to Common Diseases: Precision Medicine and the Transforming Landscape of Pediatric Allergy and Immunology.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same journal

Involution of IgE sensitization to house dust mite allergen molecules by age.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same journal

Early initiation of inhaled corticosteroid-long-acting β<sub>2</sub>-agonist therapy and reduction of severe asthma exacerbations in high-risk preschool children: A longitudinal real-world cohort study.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same journal

The role of dog keeping in the home microbiota and its impact on children's health.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same journal

PGM3-SCID: Differential impact of glycosylation on lymphocyte lineage development and function.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
See all related articles

This review highlights the role of T-helper 2 (Th2) cytokines, like interleukin-4 (IL-4) and IL-5, in allergic inflammation. These cytokines are key targets for developing new treatments for conditions involving IgE and eosinophils.

Area of Science:

  • Immunology
  • Allergic Inflammation Mechanisms

Background:

  • Allergic inflammation involves mediators and effector cells like mast cells and eosinophils.
  • Cytokines, particularly T-helper 2 (Th2) type, are increasingly recognized for their regulatory role.

Purpose of the Study:

  • To review the in vivo evidence for Th2 cytokines in human allergic inflammation.
  • To explore novel therapeutic strategies targeting Th2 cytokines.

Main Methods:

  • Review of in vivo human studies.
  • Analysis of in vitro murine and human T lymphocyte studies.
  • Examination of cytokine production by various cell types.

Main Results:

  • Th2 cytokines, including interleukin-4 (IL-4) and IL-5, are preferentially produced.

Related Experiment Videos

  • Evidence supports a primary role for Th2 cytokines in orchestrating IgE-dependent events and tissue eosinophilia in humans.

    • Conclusions:

    • Th2 cytokines are central to allergic inflammation.
    • Therapeutic strategies could involve targeting T lymphocytes broadly or specifically inhibiting IL-4 and IL-5.